Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.155
+0.025 (0.80%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $174.45 million as of April 17, 2025. Its market cap has decreased by -65.64% in one year.
Market Cap
174.45M
Enterprise Value
-114.21M
1-Year Change
-65.64%
Ranking
Category
Stock Price
$3.16
Market Cap Chart
Since November 11, 2015, Voyager Therapeutics's market cap has decreased from $456.60M to $174.45M, a decrease of -61.79%. That is a compound annual growth rate of -9.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 174.50M | -43.66% |
| Dec 31, 2024 | 309.70M | -16.59% |
| Dec 29, 2023 | 371.30M | 57.66% |
| Dec 30, 2022 | 235.50M | 128.86% |
| Dec 31, 2021 | 102.90M | -61.59% |
| Dec 31, 2020 | 267.90M | -48.20% |
| Dec 31, 2019 | 517.20M | 69.02% |
| Dec 31, 2018 | 306.00M | -31.60% |
| Dec 29, 2017 | 447.40M | 31.43% |
| Dec 30, 2016 | 340.40M | -41.89% |
| Dec 31, 2015 | 585.80M | 28.30% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.22B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.41B |
| AbbVie | 306.03B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |